JFK Johnson Rehabilitation Institute is researching a medical device that delivers electromagnetic therapy to the brain to accelerate healing after a stroke.
JFK Johnson is one of 20 rehabilitation hospitals nationwide enrolling patients in the EMAGINE Stroke Recovery Trial, which aims to enhance recovery and reduce disability after neurologic damage caused by stroke. The wearable device, which can be used in a hospital setting, outpatient clinic, and at home would augment JFK Johnson’s existing rehabilitation therapies.
The wearable device was given breakthrough status by the FDA after a pilot study showed promise.
About the Trial
The device targets networks in the brain with a low-intensity, frequency-tuned electromagnetic field therapy. JFK Johnson Rehabilitation Institute is training rehabilitation specialists to guide patients and to train caregivers to use the device. The program is over 45 hour-long sessions, five times each week, with weekly follow-up from a JFK Johnson rehabilitation specialist.
JFK Johnson treats approximately 750 stroke patients each year.
The EMAGINE trial will enroll 150 randomized subjects nationwide within four to 21 days following a stroke.